anmelden
Analysen von Matthew Weston
| 29.04.26 | Novartis Neutral | UBS AG | |
| 28.04.26 | Novartis Neutral | UBS AG | |
| 27.04.26 | Sanofi Neutral | UBS AG | |
| 24.04.26 | Sartorius vz. Neutral | UBS AG | |
| 24.04.26 | Sanofi Neutral | UBS AG | |
| 23.04.26 | Sartorius vz. Neutral | UBS AG | |
| 17.04.26 | Sartorius vz. Neutral | UBS AG | |
| 17.04.26 | Sartorius Stedim Biotech Neutral | UBS AG | |
|
Werbung
|
|||
| 10.04.26 | GSK Neutral | UBS AG | |
| 10.04.26 | Sanofi Neutral | UBS AG | |
| 10.04.26 | Novo Nordisk Neutral | UBS AG | |
| 10.04.26 | Novartis Neutral | UBS AG | |
| 30.03.26 | Sanofi Neutral | UBS AG | |
| 23.03.26 | Novartis Neutral | UBS AG | |
| 23.03.26 | Sartorius vz. Neutral | UBS AG | |
| 13.03.26 | Sartorius vz. Neutral | UBS AG | |
| 26.02.26 | GSK Neutral | UBS AG | |
| 25.02.26 | Bayer Neutral | UBS AG | |
| 23.02.26 | Novo Nordisk Neutral | UBS AG | |
| 18.02.26 | Bayer Neutral | UBS AG | |
| 06.02.26 | Novartis Neutral | UBS AG | |
| 06.02.26 | Novo Nordisk Neutral | UBS AG | |
| 06.02.26 | Bayer Neutral | UBS AG | |
| 05.02.26 | Novo Nordisk Neutral | UBS AG | |
| 04.02.26 | Novartis Neutral | UBS AG | |
| 03.02.26 | Sartorius vz. Neutral | UBS AG | |
| 02.02.26 | Sartorius vz. Neutral | UBS AG | |
| 02.02.26 | Novo Nordisk Neutral | UBS AG | |
| 29.01.26 | Sanofi Neutral | UBS AG | |
| 21.01.26 | GSK Neutral | UBS AG | |
| 21.01.26 | Novo Nordisk Neutral | UBS AG | |
| 20.01.26 | Novo Nordisk Neutral | UBS AG | |
| 19.01.26 | Bayer Neutral | UBS AG | |
| 16.01.26 | Bayer Neutral | UBS AG | |
| 16.01.26 | Sanofi Neutral | UBS AG | |
| 16.01.26 | GSK Neutral | UBS AG | |
| 16.01.26 | Novartis Neutral | UBS AG | |
| 15.01.26 | Novo Nordisk Neutral | UBS AG | |
| 15.12.25 | Novo Nordisk Neutral | UBS AG | |
| 12.12.25 | Novo Nordisk Neutral | UBS AG | |
| 04.12.25 | GSK Neutral | UBS AG | |
| 04.12.25 | Novo Nordisk Neutral | UBS AG | |
| 02.12.25 | Bayer Neutral | UBS AG | |
| 01.12.25 | Novo Nordisk Neutral | UBS AG | |
| 25.11.25 | Bayer Neutral | UBS AG | |
| 21.11.25 | Novartis Neutral | UBS AG | |
| 20.11.25 | Novartis Neutral | UBS AG | |
| 18.11.25 | Novo Nordisk Neutral | UBS AG | |
| 11.11.25 | Novo Nordisk Neutral | UBS AG | |
| 10.11.25 | Novo Nordisk Neutral | UBS AG | |